Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Accounts Receivable

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Accounts Receivable of $87.14 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-27 was $21.82M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-28 was $65.32M, a 122.53% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-27 was -$27.63M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-27 was -$26.60M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$35.74M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts receivable for fiscal 2024 was -$21.61M, a 164.64% decline from fiscal 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts receivable for fiscal 2023 was $33.43M, a 77.80% decline from fiscal 2022.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accounts receivable for fiscal 2022 was $150.57M, a 465.35% increase from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 6 month as first filedIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 9 month as first filedIncrease (Decrease) in Accounts Receivable 12 month
2026-06-27$21.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$87.14M
10-Q · filed 2026-08-05
$59.50M
derived: sum of 3 quarters · filed 2026-08-05
$32.91M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-28$65.32M
10-Q · filed 2026-05-07
$37.69M
derived: sum of 2 quarters · filed 2026-05-07
$11.09M
derived: sum of 3 quarters · filed 2026-05-07
$229.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-12-27-$27.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
-$54.23M
derived: sum of 2 quarters · filed 2026-02-18
-$65.09M
derived: sum of 3 quarters · filed 2026-08-05
-$35.74M
10-K · filed 2026-02-18
2025-09-27-$26.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$37.46M
derived: sum of 2 quarters · filed 2026-08-05
-$8.11M
10-Q · filed 2025-11-05
-$11.42M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-28-$10.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$18.49M
10-Q · filed 2026-08-05
$15.18M
derived: sum of 3 quarters · filed 2026-08-05
-$2.05M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-29$29.35M
10-Q · filed 2026-05-07
$26.04M
derived: sum of 2 quarters · filed 2026-05-07
$8.81M
derived: sum of 3 quarters · filed 2026-05-07
-$9.54M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-28-$3.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
-$20.54M
derived: sum of 2 quarters · filed 2026-02-18
-$38.89M
derived: sum of 3 quarters · filed 2026-02-18
-$21.61M
10-K · filed 2026-02-18
2024-09-28-$17.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$35.58M
derived: sum of 2 quarters · filed 2025-11-05
-$18.30M
10-Q · filed 2025-11-05
-$43.95M
derived: sum of 4 quarters · filed 2026-02-18
2024-06-29-$18.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$1.07M
10-Q · filed 2025-08-06
-$26.72M
derived: sum of 3 quarters · filed 2026-02-18
-$15.89M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-30$17.28M
10-Q · filed 2025-05-07
-$8.37M
derived: sum of 2 quarters · filed 2026-02-18
$2.47M
derived: sum of 3 quarters · filed 2026-02-18
$16.88M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-30-$25.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
-$14.81M
derived: sum of 2 quarters · filed 2026-02-18
-$397.00K
derived: sum of 3 quarters · filed 2026-02-18
$33.43M
10-K · filed 2026-02-18
2023-09-30$10.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$25.25M
derived: sum of 2 quarters · filed 2024-11-06
$59.08M
10-Q · filed 2024-11-06
$35.48M
derived: sum of 4 quarters · filed 2025-02-19
2023-07-01$14.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$48.25M
10-Q · filed 2024-08-07
$24.65M
derived: sum of 3 quarters · filed 2025-02-19
$81.18M
derived: sum of 4 quarters · filed 2025-02-19
2023-04-01$33.83M
10-Q · filed 2024-05-09
$10.23M
derived: sum of 2 quarters · filed 2025-02-19
$66.76M
derived: sum of 3 quarters · filed 2025-02-19
$126.46M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31-$23.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
$32.93M
derived: sum of 2 quarters · filed 2025-02-19
$92.63M
derived: sum of 3 quarters · filed 2025-02-19
$150.57M
10-K · filed 2025-02-19
2022-09-24$56.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$116.23M
derived: sum of 2 quarters · filed 2023-11-08
$174.17M
10-Q · filed 2023-11-08
$165.21M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-25$59.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$117.64M
10-Q · filed 2023-08-09
$108.68M
derived: sum of 3 quarters · filed 2024-02-14
$139.05M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-26$57.94M
10-Q · filed 2023-05-11
$48.98M
derived: sum of 2 quarters · filed 2024-02-14
$79.35M
derived: sum of 3 quarters · filed 2024-02-14
$90.17M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-25-$8.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$21.41M
derived: sum of 2 quarters · filed 2024-02-14
$32.23M
derived: sum of 3 quarters · filed 2024-02-14
$26.63M
10-K · filed 2024-02-14
2021-09-25$30.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$41.19M
derived: sum of 2 quarters · filed 2022-11-02
$35.59M
10-Q · filed 2022-11-02
$69.76M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-26$10.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$5.22M
10-Q · filed 2022-08-03
$39.40M
derived: sum of 3 quarters · filed 2023-02-22
$71.48M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-27-$5.60M
10-Q · filed 2022-05-04
$28.57M
derived: sum of 2 quarters · filed 2023-02-22
$60.66M
derived: sum of 3 quarters · filed 2023-02-22
$47.89M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-26$34.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$66.26M
derived: sum of 2 quarters · filed 2023-02-22
$53.49M
derived: sum of 3 quarters · filed 2023-02-22
$85.63M
10-K · filed 2023-02-22
2020-09-26$32.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$19.32M
derived: sum of 2 quarters · filed 2021-11-03
$51.46M
10-Q · filed 2021-11-03
$35.29M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-27-$12.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$19.37M
10-Q · filed 2021-08-04
$3.20M
derived: sum of 3 quarters · filed 2022-02-16
-$8.84M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-28$32.14M
10-Q · filed 2021-05-04
$15.97M
derived: sum of 2 quarters · filed 2022-02-16
$3.92M
derived: sum of 3 quarters · filed 2022-02-16
$17.33M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-28-$16.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
-$28.21M
derived: sum of 2 quarters · filed 2022-02-16
-$14.80M
derived: sum of 3 quarters · filed 2022-02-16
$8.32M
10-K · filed 2022-02-16
2019-09-28-$12.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$1.36M
derived: sum of 2 quarters · filed 2020-10-29
$24.49M
10-Q · filed 2020-10-29
$15.37M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-29$13.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$36.54M
10-Q · filed 2020-08-05
$27.42M
derived: sum of 3 quarters · filed 2021-02-17
$38.36M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-30$23.13M
10-Q · filed 2020-05-07
$14.01M
derived: sum of 2 quarters · filed 2021-02-17
$24.95M
derived: sum of 3 quarters · filed 2021-02-17
$40.54M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-29-$9.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
$1.82M
derived: sum of 2 quarters · filed 2021-02-17
$17.42M
derived: sum of 3 quarters · filed 2021-02-17
$21.20M
10-K · filed 2021-02-17
2018-09-29$10.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$26.54M
derived: sum of 2 quarters · filed 2019-11-06
$30.32M
10-Q · filed 2019-11-06
$35.88M
derived: sum of 4 quarters · filed 2020-02-11
2018-06-30$15.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
$19.38M
10-Q · filed 2019-07-31
$24.94M
derived: sum of 3 quarters · filed 2020-02-11
$41.06M
derived: sum of 4 quarters · filed 2020-02-11
2018-03-31$3.78M
10-Q · filed 2019-05-07
$9.35M
derived: sum of 2 quarters · filed 2020-02-11
$25.46M
derived: sum of 3 quarters · filed 2020-02-11
$31.00M
derived: sum of 4 quarters · filed 2020-02-11
2017-12-30$5.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11
$21.68M
derived: sum of 2 quarters · filed 2020-02-11
$27.22M
derived: sum of 3 quarters · filed 2020-02-11
$48.28M
10-K · filed 2020-02-11
2017-09-30$16.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$21.65M
derived: sum of 2 quarters · filed 2018-11-07
$42.71M
10-Q · filed 2018-11-07
$52.23M
derived: sum of 4 quarters · filed 2019-02-13
2017-07-01$5.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$26.60M
10-Q · filed 2018-08-08
$36.12M
derived: sum of 3 quarters · filed 2019-02-13
$51.74M
derived: sum of 4 quarters · filed 2019-02-13
2017-04-01$21.06M
10-Q · filed 2018-05-10
$30.58M
derived: sum of 2 quarters · filed 2019-02-13
$46.21M
derived: sum of 3 quarters · filed 2019-02-13
$57.56M
derived: sum of 4 quarters · filed 2019-02-13
2016-12-31$9.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13
$25.14M
derived: sum of 2 quarters · filed 2019-02-13
$36.50M
derived: sum of 3 quarters · filed 2019-02-13
$52.78M
10-K · filed 2019-02-13
2016-09-24$15.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$26.98M
derived: sum of 2 quarters · filed 2017-11-09
$43.26M
10-Q · filed 2017-11-09
$23.79M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-25$11.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$27.64M
10-Q · filed 2017-08-09
$8.17M
derived: sum of 3 quarters · filed 2018-02-13
$20.02M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-26$16.28M
10-Q · filed 2017-05-10
-$3.19M
derived: sum of 2 quarters · filed 2018-02-13
$8.67M
derived: sum of 3 quarters · filed 2018-02-13
$14.94M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-26-$19.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
-$7.61M
derived: sum of 2 quarters · filed 2018-02-13
-$1.34M
derived: sum of 3 quarters · filed 2018-02-13
$16.96M
10-K · filed 2018-02-13
2015-09-26$11.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$18.13M
derived: sum of 2 quarters · filed 2016-11-02
$36.43M
10-Q · filed 2016-11-02
$23.56M
derived: sum of 4 quarters · filed 2017-02-14
2015-06-27$6.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$24.57M
10-Q · filed 2016-08-03
$11.70M
derived: sum of 3 quarters · filed 2017-02-14
$21.50M
derived: sum of 4 quarters · filed 2017-02-14
2015-03-28$18.30M
10-Q · filed 2016-05-04
$5.43M
derived: sum of 2 quarters · filed 2017-02-14
$15.23M
derived: sum of 3 quarters · filed 2017-02-14
$26.17M
derived: sum of 4 quarters · filed 2017-02-14
2014-12-27-$12.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
-$3.07M
derived: sum of 2 quarters · filed 2017-02-14
$7.86M
derived: sum of 3 quarters · filed 2017-02-14
$28.09M
10-K · filed 2017-02-14
2014-09-27$9.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$20.74M
derived: sum of 2 quarters · filed 2015-11-04
$40.96M
10-Q · filed 2015-11-04
$37.79M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-28$10.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$31.16M
10-Q · filed 2015-07-30
$27.99M
derived: sum of 3 quarters · filed 2016-02-12
$24.20M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-29$20.22M
10-Q · filed 2015-04-30
$17.05M
derived: sum of 2 quarters · filed 2016-02-12
$13.27M
derived: sum of 3 quarters · filed 2016-02-12
$25.48M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-28-$3.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
-$6.96M
derived: sum of 2 quarters · filed 2016-02-12
$5.26M
derived: sum of 3 quarters · filed 2016-02-12
$19.49M
10-K · filed 2016-02-12
2013-09-28-$3.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
$8.43M
derived: sum of 2 quarters · filed 2014-10-30
$22.66M
10-Q · filed 2014-10-30
$11.00M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-29$12.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$26.45M
10-Q · filed 2014-08-07
$14.79M
derived: sum of 3 quarters · filed 2015-02-17
$17.33M
derived: sum of 4 quarters · filed 2015-02-17
2013-03-30$14.23M
10-Q · filed 2014-04-30
$2.57M
derived: sum of 2 quarters · filed 2015-02-17
$5.11M
derived: sum of 3 quarters · filed 2015-02-17
$10.62M
derived: sum of 4 quarters · filed 2015-02-17
2012-12-29-$11.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
-$9.12M
derived: sum of 2 quarters · filed 2015-02-17
-$3.62M
derived: sum of 3 quarters · filed 2015-02-17
$16.27M
10-K · filed 2015-02-17
2012-09-29$2.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
$8.05M
derived: sum of 2 quarters · filed 2013-10-30
$27.93M
10-Q · filed 2013-10-30
$11.79M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$5.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31
$25.39M
10-Q · filed 2013-07-31
$9.25M
derived: sum of 3 quarters · filed 2014-02-25
$3.50M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$19.88M
10-Q · filed 2013-05-08
$3.75M
derived: sum of 2 quarters · filed 2014-02-25
-$2.01M
derived: sum of 3 quarters · filed 2014-02-25
-$4.95M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31-$16.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
-$21.89M
derived: sum of 2 quarters · filed 2014-02-25
-$24.84M
derived: sum of 3 quarters · filed 2014-02-25
-$7.67M
10-K · filed 2014-02-25
2011-09-24-$5.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
-$8.70M
derived: sum of 2 quarters · filed 2012-11-01
$8.47M
10-Q · filed 2012-11-01
-$8.49M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-25-$2.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
$14.22M
10-Q · filed 2012-08-07
-$2.74M
derived: sum of 3 quarters · filed 2013-02-27
-$10.47M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-26$17.17M
10-Q · filed 2012-05-04
$205.00K
derived: sum of 2 quarters · filed 2013-02-27
-$7.52M
derived: sum of 3 quarters · filed 2013-02-27
-$5.30M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-25-$16.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
-$24.69M
derived: sum of 2 quarters · filed 2013-02-27
-$22.46M
derived: sum of 3 quarters · filed 2013-02-27
$5.64M
10-K · filed 2013-02-27
2010-09-25-$7.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
-$5.50M
derived: sum of 2 quarters · filed 2011-11-02
$22.60M
10-Q · filed 2011-11-02
$21.79M
10-Q · filed 2010-11-04
$7.15M
derived: sum of 4 quarters · filed 2012-02-27
2010-06-26$2.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03
$30.33M
10-Q · filed 2011-08-03
$29.65M
10-Q · filed 2010-08-03
$14.88M
derived: sum of 3 quarters · filed 2012-02-27
$12.82M
derived: sum of 4 quarters · filed 2012-02-27
2010-03-27$28.11M
10-Q · filed 2011-05-04
$12.65M
derived: sum of 2 quarters · filed 2012-02-27
$10.59M
derived: sum of 3 quarters · filed 2012-02-27
2009-12-26-$15.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
-$17.51M
derived: sum of 2 quarters · filed 2012-02-27
-$21.08M
10-K · filed 2012-02-27
2009-09-26-$2.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04
-$5.63M
10-Q · filed 2010-11-04
2009-06-27-$3.57M
10-Q · filed 2010-08-03
2008-12-27$11.17M
10-K · filed 2011-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71